Shineco (SISI) announced the execution of a “Cellular Asset On-Chaining and Marketing Ecosystem Cooperation Agreement” with blockchain infrastructure provider Plus Me Limited. This partnership enables blockchain-based tokenization of biological cellular assets, facilitating global transfers and auditable standardized custody, creating an ‘Asset On-Chaining + Application Scenarios’ model in cell therapy. Under the agreement, Plus Me will deploy full lifecycle digital custody of Shineco’s compliant mesenchymal stem cells on the Ethereum mainnet. Smart contracts will immutably secure asset ownership rights, issuing non-fungible digital identifiers for each cellular asset to ensure traceability and compliance. Verifiable uniqueness and regulatory compliance are cryptographically enforced through on-chain hashing. Shineco has secured a controlling 51% stake in Xi’an Dong’ao Health Management, a specialist in cryogenic cell storage and clinical applications, provides the off-chain infrastructure critical to token redemption, as of August 18.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SISI: